Navigation Links
'Black Box' Drug Warning Labels Applied Inconsistently: Study
Date:2/4/2011

FRIDAY, Feb. 4 (HealthDay News) -- Safety labels that outline concerns about medications, known as "black box warnings," are not always consistent within drug categories, a new study suggests.

These warnings should be rendered uniform for all medications within a single class of drugs, according to a team of researchers from Greece and the United States. The team also advised that supplemental warnings (for example, following a drug withdrawal) should be added in a reasonable timeframe.

The research team published their report Feb. 2 in the Journal of General Internal Medicine.

"Our findings imply that the process of black box warning acquisition requires transparent and systematic rules, as well as clear justification for the presence of, or lack of evidence for, specific major risks for individual drugs," the research team led by Orestis Panagiotou from the University of Ioannina's School of Medicine in Greece, said in a journal news release.

The authors pointed out that black box warnings are the strongest tool the U.S Food and Drug Administration has to issue consumer safety warnings and outline drug risks. Most warnings are issued per class of drugs, rather than for an individual drug, because concerning side effects usually apply broadly to a type of drug rather than to a single medication.

Therefore, the team focused on analyzing black box warning labels placed on drugs that all fell within the same drug class.

The investigators examined 20 different drug classes that in total covered 176 medications, all chosen from data included in the USA's "Top 200 Drugs for 2008 by Sales" report.

Half of the 20 drug classes had at least a single black box warning issued; the other half had no such warnings.

Black box warning inconsistencies were found in nine drug classes, with 15 specific warnings not uniformly evident on the labeling of all drugs that fell within each specific class.

In two-thirds of these (10 of the 15), the information was, in fact, noted on the labels in a different place, as either a simple warning or plain text. The rest did not include the warnings anywhere on the label.

What's more, specific drugs subject to a withdrawal from the market were not typically outfitted with a black box warning prior to a withdrawal, the team found. And drugs similar to the withdrawn medication were frequently not labeled with a relevant black box warning referencing the concerns that led to the withdrawal in question.

A significant time lag in the posting of black box warnings was also commonly observed (ranging from two months to 14 years) for drugs that fell into classes in which similar drugs were subject to the warning.

The authors suggested that if a drug is in the same class as another drug that requires a black box warning, but the warning does not apply to that particular medication, the warning label should specifically explain why this is the case to ease consumer confusion.

More information

For more information on black box warnings, visit the U.S. Agency for Healthcare Research and Quality.

-- Alan Mozes

SOURCE: Journal of General Internal Medicine, news release, Feb. 2, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Burden of HIV Highest for Blacks, CDC Reports
2. Blacks Still Hit Hardest by Cancer
3. Study Examines Reasons Some Black Men Avoid Doctors
4. Survival After Stroke Better for Blacks
5. Gene Mutation May Protect Blacks From Heart Disease
6. Distrust of Health System Keeps Black Males From Getting Care
7. Wiley-Blackwell announces 102 additional products available through Research4Life
8. Blacks with liver cancer more likely to die, study finds
9. Liver Cancer Survival Rates May Be Worse for Blacks
10. Black, Low-Income Patients More Disabled by Parkinsons Complications
11. New American Chemical Society podcast: Black rice bran may reduce inflammation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Black Box' Drug Warning Labels Applied Inconsistently: Study
(Date:10/13/2017)... Ky. (PRWEB) , ... October 13, 2017 , ... The ... MPH to become its next President and Chief Executive Officer, succeeding Dr. James C. ... CEO Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of ...
(Date:10/13/2017)... EDWARDSVILLE, Ill. (PRWEB) , ... ... ... University Edwardsville School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and ... educated healthcare professionals on guideline updates for the primary prevention of cardiovascular ...
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual ... in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon ... fun run is geared towards children of all ages; it is a non-competitive, non-timed ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 12, 2017 AVACEN Medical , Inc. (AVACEN) ... their  2017 New Product Innovation Award for Its fibromyalgia ... and secondary medical device market research by Frost & Sullivan,s ... OTC, drug-free pain relief product, the AVACEN 100, offers a ... fibromyalgia widespread pain. ...
(Date:10/12/2017)... EXTON, Pa. , Oct. 12, 2017 ... global leader in innovative solutions for injectable drug administration, ... results before the market opens on Thursday, October 26, ... discuss the results and business expectations at 9:00 a.m. ... 877-930-8295 (U.S.) or 253-336-8738 (International). The conference ID is ...
(Date:10/11/2017)... Oct. 11, 2017  Caris Life Sciences ® , ... the promise of precision medicine, today announced that St. ... Precision Oncology Alliance™ (POA) as its 17 th ... St. Jude Crosson Cancer Institute will help develop standards ... of tumor profiling, making cancer treatment more precise and ...
Breaking Medicine Technology: